ABSTRACT
Psoriasis is a common, chronic, and recurrent inflammatory disease characterized by heritability, phenotypic variability, and possible association to psoriatic arthritis and metabolic syndrome. Psoriasis is considered as a hyperproliferative disorder, but this increased proliferation of keratinocytes is the result of a cascade of immunologic reactions driven by inflammatory mediator cells and cytokines.1–3
